It is named after the two persons who first described it: Ernst Fuchs, who described a pigmented lesion in 1901, and Forster, who described subretinal neovascularization in 1862.

[2] It occurs due to proliferation of retinal pigment epithelium associated with choroidal hemorrhage.

[1] The size of the spots are proportionate to the severity of the pathological myopia.

First signs of a Fuchs spot are distorted sight of straight lines near the fovea, which some days later turn to the typical well-circumscribed patches after absorption of haemorrhage, and a pigmented scar remains.

Photothermal laser ablation, photodynamic therapy, anti-VEGF therapy, or a combination of these are the treatment options of choroidal neovascularization due to pathological myopia.